PortfoliosLab logoPortfoliosLab logo

Simplify Propel Opportunities ETF (SURI) belongs to the Health & Biotech Equities category. Below you'll find alternative ETFs from the same category, ranked by key criteria, plus funds that investors commonly compare with SURI. Use the tables to find lower-cost options, better risk-adjusted returns, or a closer substitute for your current allocation.

Cheapest Alternatives to SURI

SURI charges 2.51% annually. There are 66 ETFs in the Health & Biotech Equities category with lower expense ratios, going as low as 0.08%.


Best Risk-Adjusted Alternatives to SURI

SURI has a PortfoliosLab risk / return rank of 78. There are 22 ETFs in the Health & Biotech Equities category with higher risk-adjusted ranks, going as high as 96.


Top Performing SURI Alternatives (YTD)

SURI is at 17.59% YTD. There are 17 ETFs in the Health & Biotech Equities category with higher YTD returns, going as high as 36.76%.


Lowest Volatility Alternatives to SURI

SURI has 22.20% 1-year volatility. There are 43 ETFs in the Health & Biotech Equities category with lower 1-year volatility, going as low as 0.00%.


Lowest Drawdown Alternatives to SURI

SURI has a 1-year max drawdown of -11.78%. There are 28 ETFs in the Health & Biotech Equities category with shallower 1-year drawdowns, going as shallow as 0.00%.


Other ETFs from Simplify

The 10 most viewed Simplify ETFs shown here include SVOL, CTA, HEQT and span 15 categories. AUM among these funds goes as high as $2B.


Often Compared With SURI

Investors most often compare SURI with AIPI, PEX, LIFE.TO. These 20 comparison targets span 9 categories, based on PortfoliosLab usage data.


SymbolNameCategoryRisk / Return RankYTD ReturnAUMInception
REX AI Equity Premium Income ETFDerivative Income
35
5.87%
399.20MJun 2024SURI vs AIPI
ProShares Global Listed Private Equity ETFFinancials Equities
5
-5.43%
11.02MFeb 2013SURI vs PEX
Evolve Global Healthcare Enhanced Yield FundHealth & Biotech Equities, Derivative Income, Options Trading, Global Equities
28
-1.47%
345.82MOct 2017SURI vs LIFE.TO
YieldMax™ MSTR Option Income Strategy ETFDerivative Income
1
-32.53%
756.67MFeb 2024SURI vs MSTY
State Street SPDR S&P 500 ETFS&P 500
78
11.70%
789.06BJan 1993SURI vs SPY
Global X NASDAQ 100 Covered Call ETFNasdaq-100, Derivative Income
87
8.73%
8.09BDec 2013SURI vs QYLD
S&P 500 Index
79
11.03%
SURI vs ^GSPC
Clockwise U.S. Core Equity ETFTechnology Equities
44
7.94%
19.49MJan 2022SURI vs TIME
iShares U.S. Healthcare ETFHealth & Biotech Equities
65
5.42%
3.56BJun 2000SURI vs IYH
F/m Emerald Life Sciences Innovation ETFHealth & Biotech Equities
94
24.59%
74.65MOct 2024SURI vs LFSC
FT Vest DJIA Dogs 10 Target Income ETFDerivative Income
72
11.00%
88.80MApr 2023SURI vs DOGG
Global X Aging Population ETFHealth & Biotech Equities
44
3.77%
87.24MMay 2016SURI vs AGNG
WisdomTree BioRevolution FundHealth & Biotech Equities
78
15.67%
2.55MJun 2021SURI vs WDNA
Tema Oncology ETFHealth & Biotech Equities
91
16.11%
193.73MAug 2023SURI vs CANC
iShares Genomics Immunology and Healthcare ETFHealth & Biotech Equities
88
24.31%
190.86MJun 2019SURI vs IDNA
Jpmorgan Healthcare Leaders ETFHealth & Biotech Equities
63
4.29%
9.07MNov 2023SURI vs JDOC
Invesco S&P SmallCap Health Care ETFHealth & Biotech Equities
78
21.97%
165.04MApr 2010SURI vs PSCH
Invesco S&P 500 Equal Weight Health Care ETFHealth & Biotech Equities, S&P 500, Equal Weight
67
10.63%
766.87MNov 2006SURI vs RSPH
VanEck Biotech ETFHealth & Biotech Equities
56
7.93%
399.88MDec 2011SURI vs BBH
iShares Global Healthcare ETFHealth & Biotech Equities
56
3.49%
4.09BNov 2001SURI vs IXJ

Compare SURI with Any Fund or Stock

Compare SURI with any ETF, mutual fund, or stock using PortfoliosLab's comparison tool.


 

Diversifiers

Pair SURI with funds that move differently

Simplify Propel Opportunities ETF alternatives help with substitution. Diversifiers are the next step when you want funds with lower historical correlation to SURI.

Explore SURI Diversifiers